Haiti | Page 374 | Resilience System

BBC ANALYSIS: Covid-19 in the US: Is this coronavirus wave the worst yet?

Tue, 2020-11-17 10:48 — mike kraft

Covid-19 in the US: Is this coronavirus wave the worst yet? The pandemic has quietly been getting worst across the US, with record numbers of cases in recent days. BBC News

Americans may have tuned out of coronavirus news as they focused on the outcome of the presidential election, but the pandemic has quietly been getting worse in the country.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about BBC ANALYSIS: Covid-19 in the US: Is this coronavirus wave the worst yet?
Log in or register to post comments

Hospital-Acquired SARS-CoV-2 InfectionLessons for Public Health

Mon, 2020-11-16 20:23 — mike kraft

Hospital-Acquired SARS-CoV-2 Infection This Viewpoint reviews the rare incidence of nosocomial SARS-CoV-2 infection and discusses ways it can be minimized, including use of surgical masks, proper ventilation, physical distancing, eye protection, regular testing, and the availability of sick leave for health care workers. JAMA_current

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Hospital-Acquired SARS-CoV-2 InfectionLessons for Public Health
Log in or register to post comments

WHO tempers prospect of a coronavirus vaccine with warning of a long distribution fight to come

Mon, 2020-11-16 19:33 — mike kraft

WHO tempers prospect of a coronavirus vaccine with warning of a long fight to come Finding a coronavirus vaccine is like building a base camp on Mount Everest, not reaching the summit, the WHO says. Adam Taylor Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about WHO tempers prospect of a coronavirus vaccine with warning of a long distribution fight to come
Log in or register to post comments

Pfizer vs Moderna vaccines: What we know, and what we don't

Mon, 2020-11-16 19:21 — mike kraft

Pfizer vs Moderna vaccines: What we know, and what we don't Two vaccine candidates using similar technology are winning the COVID-19 vaccine race in the U.S., and in the process validating the mRNA platform — which is yet untested on the market— as well as setting the path for vaccine makers to follow in order to block the virus. YahooNews

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Pfizer vs Moderna vaccines: What we know, and what we don't
Log in or register to post comments

But Landon and other experts say people should be cautious when using risk assessment tools and not rely too heavily on a single source, which could create a false sense of security as cases continue to surge

Mon, 2020-11-16 12:42 — mike kraft

Why experts urge caution in using covid risk and tracking tools As coronavirus cases surge ahead of Thanksgiving and the holiday season, relying on a single tool or data point could create a false sense of security, experts say. Allyson Chiu Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Researchers find coronavirus was circulating in Italy earlier than thought

Mon, 2020-11-16 11:15 — mike kraft

Researchers find coronavirus was circulating in Italy earlier than thought The new coronavirus was circulating in Italy in September 2019, a study by the National Cancer Institute (INT) of the Italian city of Milan shows, signaling that it might have spread beyond China earlier than thought. Giselda Vagnoni U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Researchers find coronavirus was circulating in Italy earlier than thought
1 comment
Log in or register to post comments

Moderna, 2nd virus vaccine shows overwhelming success in U.S. tests

Mon, 2020-11-16 10:26 — mike kraft

2nd virus vaccine shows overwhelming success in U.S. tests Moderna said Monday its COVID-19 vaccine is proving to be highly effective in a major trial, a second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more... AP NEWS

Moderna said Monday its COVID-19 vaccine is proving to be highly effective in a major trial, a second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Moderna, 2nd virus vaccine shows overwhelming success in U.S. tests
Log in or register to post comments

States enact more Covid-19 rules as the US hits 11 million cases

Sun, 2020-11-15 17:37 — mike kraft

States enact more Covid-19 rules as the US hits 11 million cases At least 45 states have reported more new infections this past week compared to the previous week. And while some officials toughen their restrictions, some say changing behavior is more important than shutting down. Holly Yan and Madeline Holcombe, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about States enact more Covid-19 rules as the US hits 11 million cases
Log in or register to post comments

Biden COVID-19 adviser: We can get pandemic under control without another national lockdown

Sun, 2020-11-15 12:07 — mike kraft

Biden COVID-19 adviser: We can get pandemic under control without Dr. Joseph Choi TheHill

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Biden COVID-19 adviser: We can get pandemic under control without another national lockdown
Log in or register to post comments

Recovering Covid-19 patients struggle to return to normal after hospital discharge, new study finds

Sat, 2020-11-14 11:52 — mike kraft

Recovering Covid-19 patients struggle to return to normal after hospital discharge, study finds Surviving Covid-19 is hard enough for those who get severely ill from the disease, but returning to normal is a struggle, too, according to new research that found survivors were likely to face health and financial hardships even months later. Shelby Lin Erdman and Jacqueline Howard, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Problem

Situation Report

Read more about Recovering Covid-19 patients struggle to return to normal after hospital discharge, new study finds
Log in or register to post comments

International roundup of COVID-19 developments -Reuters

Sat, 2020-11-14 11:24 — mike kraft

Latest on worldwide spread of the coronavirus Delhi's COVID-19 deaths rose by a record number on Thursday and it reported the most infections in India, as government officials in Germany dampened hopes that a partial lockdown there would be lifted at the end of November. Reuters Staff U.S.

Reuters) - Delhi’s COVID-19 deaths rose by a record number on Thursday and it reported the most infections in India, as government officials in Germany dampened hopes that a partial lockdown there would be lifted at the end of November.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about International roundup of COVID-19 developments -Reuters
Log in or register to post comments

What's next for COVID-19 apps? Governance and oversight

Fri, 2020-11-13 19:41 — mike kraft

Science Article

Studies conducted in April and May 2020 showed that in countries like the United States, Switzerland, and Italy, between 55 and 70% of adults in all age groups were willing to download a contact tracing app (5).

Yet these figures do not match the current DCT apps uptake. Even in countries with robust privacy safeguards in place, downloads of DCT apps have been below expectations. At the time of writing, the Australian DCT app has been downloaded by 6.5 million (26% of the population), the Italian one by 8 million (13.4%), and the newly released French one by 1.5 million (2.3%). Ireland has about 1.3 million active app users (24%), Switzerland 1.8 million (21.5%), and Germany 16 million (19.3%).

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about What's next for COVID-19 apps? Governance and oversight
Log in or register to post comments

Microsoft: Russian, North Korean hackers target vaccine work

Fri, 2020-11-13 19:05 — mike kraft

Microsoft: Russian, North Korean hackers target vaccine work BOSTON (AP) — Microsoft said it has detected attempts by state-backed Russian and North Korean hackers to steal valuable data from leading pharmaceutical companies and vaccine... AP NEWS

BOSTON (AP) — Microsoft said it has detected attempts by state-backed Russian and North Korean hackers to steal valuable data from leading pharmaceutical companies and vaccine researchers.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about Microsoft: Russian, North Korean hackers target vaccine work
Log in or register to post comments

British Study: Black people 'twice as likely to catch coronavirus'

Fri, 2020-11-13 17:41 — mike kraft

Black people 'twice as likely to catch coronavirus' The largest analysis so far indicates black and Asian people are at higher risk. BBC News

Black people are twice as likely as white people to catch the coronavirus, a study of 18 million people suggests.

The research also indicates Asian people are 1.5 times more likely than white people to be infected - and may be more likely to need intensive care.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about British Study: Black people 'twice as likely to catch coronavirus'
Log in or register to post comments

How Pfizer Plans to Distribute Its Vaccine (It’s Complicated)

Fri, 2020-11-13 15:24 — mike kraft

For months, scientists and public health experts have been saying the most crucial part of defusing the Covid-19 pandemic will be developing a safe and effective vaccine. So it was cause for celebration this week when Pfizer announced that an early analysis showed its vaccine candidate was more than 90 percent effective.

Now the drug maker, the government and the public health community face a new challenge: quickly making millions of doses of the vaccine and getting them to the hospitals, clinics and pharmacies where they will be injected, two separate times, into people’s arms.

Country / Region Tags:

General Topic Tags: